← Ishga qaytish
Ushbu ishga iqtibos qilgan ishlar
2 ta ish
Ish: Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial